| Topoisomerase I inhibitors: Challenges, progress and the road ahead A Talukdar, B Kundu, D Sarkar, S Goon, MA Mondal European Journal of Medicinal Chemistry 236, 114304, 2022 | 51 | 2022 |
| Activity-guided development of potent and selective toll-like receptor 9 antagonists B Paul, O Rahaman, S Roy, S Pal, S Satish, A Mukherjee, AR Ghosh, ... European Journal of Medicinal Chemistry 159, 187-205, 2018 | 17 | 2018 |
| Synthesis and characterization of new potent TLR7 antagonists based on analysis of the binding mode using biomolecular simulations S Pal, B Paul, P Bandopadhyay, N Preethy, D Sarkar, O Rahaman, ... European Journal of Medicinal Chemistry 210, 112978, 2021 | 10 | 2021 |
| Abstract B43: Novel small-molecule human STING agonists generate robust Type I interferon responses in tumors M Banerjee, S Middya, S Basu, R Shrivastava, R Ghosh, D Yadav, ... Cancer Immunology Research 6 (9_Supplement), B43-B43, 2018 | 5 | 2018 |
| Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis D Sarkar, S Chowdhury, S Goon, A Sen, UG Dastidar, MA Mondal, ... Journal of Medicinal Chemistry 66 (24), 16728-16761, 2023 | 3 | 2023 |
| Exploring the Structural Attributes of Yoda1 for the Development of New-Generation Piezo1 Agonist Yaddle1 as a Vaccine Adjuvant Targeting Optimal T Cell Activation S Goon, C Shiu Chen Liu, U Ghosh Dastidar, B Paul, S Mukherjee, ... Journal of Medicinal Chemistry 67 (10), 8225-8246, 2024 | 2 | 2024 |
| Quinazolinones derivatives for treatment of non-alcoholic fatty liver disease, preparation and use thereof A Talukdar, P Chakrabarti, D Sarkar, S Chowdhury, S Goon, S Das, N Das, ... US Patent App. 18/013,681, 2023 | 1 | 2023 |
| Hit-to-lead optimization of 2-aminoquinazolines as anti-microbial agents against Leishmania donovani N Das, J Roy, B Patra, E Saunders, D Sarkar, S Goon, BP Sinha, S Roy, ... European Journal of Medicinal Chemistry 269, 116256, 2024 | | 2024 |
